|
1
|
Koch U, Krause M and Baumann M: Cancer
stem cells at the crossroads of current cancer therapy failures -
radiation oncology perspective. Semin Cancer Biol. 20:116–124.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park CH, Bergsagel DE and McCulloch EA:
Mouse myeloma tumor stem cells: A primary cell culture assay. J
Natl Cancer Inst. 46:411–422. 1971.PubMed/NCBI
|
|
3
|
Bonnet D and Dick J: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Riethdorf S, Wikman H and Pantel K:
Review: Biological relevance of disseminated tumor cells in cancer
patients. Int J Cancer. 123:1991–2006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fusi A, Collette S, Busse A, Suciu S,
Rietz A, Santinami M, Kruit WH, Testori A, Punt CJ, Dalgleish AG,
et al: Circulating melanoma cells and distant metastasis-free
survival in stage III melanoma patients with or without adjuvant
interferon treatment (EORTC 18991 side study). Eur J Cancer.
45:3189–3197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Swindle P, Eastham JA, Ohori M, Kattan MW,
Wheeler T, Maru N, Slawin K and Scardino PT: Do margins matter? The
prognostic significance of positive surgical margins in radical
prostatectomy specimens. J Urol. 179(Suppl): S47–S51. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Loree TR and Strong EW: Significance of
positive margins in oral cavity squamous carcinoma. Am J Surg.
160:410–414. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barrow BJ, Janjan NA, Gutman H, Benjamin
RS, Allen P, Romsdahl MM, Ross MI and Pollock RE: Role of
radiotherapy in sarcoma of the breast - a retrospective review of
the M.D. Anderson experience. Radiother Oncol. 52:173–178. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alektiar KM, Velasco J, Zelefsky MJ,
Woodruff JM, Lewis JJ and Brennan MF: Adjuvant radiotherapy for
margin-positive high-grade soft tissue sarcoma of the extremity.
Int J Radiat Oncol Biol Phys. 48:1051–1058. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Patel P and Chen EI: Cancer stem cells,
tumor dormancy, and metastasis. Front Endocrinol (Lausanne).
3:1252012.
|
|
11
|
Schepers AG, Snippert HJ, Stange DE, van
den Born M, van Es JH, van de Wetering M and Clevers H: Lineage
tracing reveals Lgr5+ stem cell activity in mouse
intestinal adenomas. Science. 337:730–735. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar
|
|
15
|
Ehata S, Johansson E, Katayama R, Koike S,
Watanabe A, Hoshino Y, Katsuno Y, Komuro A, Koinuma D, Kano MR, et
al: Transforming growth factor-β decreases the cancer-initiating
cell population within diffuse-type gastric carcinoma cells.
Oncogene. 30:1693–1705. 2011. View Article : Google Scholar
|
|
16
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin AH, Miraglia S, Zanjani ED,
Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J and Buck
DW: AC133, a novel marker for human hematopoietic stem and
progenitor cells. Blood. 90:5002–5012. 1997.
|
|
18
|
Uchida N, Buck DW, He D, Reitsma MJ, Masek
M, Phan TV, Tsukamoto AS, Gage FH and Weissman IL: Direct isolation
of human central nervous system stem cells. Proc Natl Acad Sci USA.
97:14720–14725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
20
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar
|
|
21
|
Murat A, Migliavacca E, Gorlia T, Lambiv
WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven
MC, et al: Stem cell-related 'self-renewal' signature and high
epidermal growth factor receptor expression associated with
resistance to concomitant chemoradiotherapy in glioblastoma. J Clin
Oncol. 26:3015–3024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tamura K, Aoyagi M, Wakimoto H, Ando N,
Nariai T, Yamamoto M and Ohno K: Accumulation of CD133-positive
glioma cells after high-dose irradiation by Gamma Knife surgery
plus external beam radiation. J Neurosurg. 113:310–318. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saigusa S, Tanaka K, Toiyama Y, Yokoe T,
Okugawa Y, Kawamoto A, Yasuda H, Morimoto Y, Fujikawa H, Inoue Y,
et al: Immunohistochemical features of CD133 expression:
Association with resistance to chemoradiotherapy in rectal cancer.
Oncol Rep. 24:345–350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shien K, Toyooka S, Ichimura K, Soh J,
Furukawa M, Maki Y, Muraoka T, Tanaka N, Ueno T, Asano H, et al:
Prognostic impact of cancer stem cell-related markers in non-small
cell lung cancer patients treated with induction chemoradiotherapy.
Lung Cancer. 77:162–167. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shmelkov SV, Butler JM, Hooper AT, Hormigo
A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, et
al: CD133 expression is not restricted to stem cells, and both
CD133+ and CD133− metastatic colon cancer
cells initiate tumors. J Clin Invest. 118:2111–2120.
2008.PubMed/NCBI
|
|
26
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ji J, Yamashita T, Budhu A, Forgues M, Jia
HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, et al: Identification
of microRNA-181 by genome-wide screening as a critical player in
EpCAM-positive hepatic cancer stem cells. Hepatology. 50:472–480.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma S, Tang KH, Chan YP, Lee TK, Kwan PS,
Castilho A, Ng I, Man K, Wong N, To KF, et al: miR-130b promotes
CD133(+) liver tumor-initiating cell growth and self-renewal via
tumor protein 53-induced nuclear protein 1. Cell Stem Cell.
7:694–707. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu C, Kelnar K, Liu B, Chen X,
Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et
al: The microRNA miR-34a inhibits prostate cancer stem cells and
metastasis by directly repressing CD44. Nat Med. 17:211–215. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iliopoulos D, Lindahl-Allen M, Polytarchou
C, Hirsch HA, Tsichlis PN and Struhl K: Loss of miR-200 inhibition
of Suz12 leads to polycomb-mediated repression required for the
formation and maintenance of cancer stem cells. Mol Cell.
39:761–772. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sagar J, Chaib B, Sales K, Winslet M and
Seifalian A: Role of stem cells in cancer therapy and cancer stem
cells: A review. Cancer Cell Int. 7:92007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bixby S, Kruger GM, Mosher JT, Joseph NM
and Morrison SJ: Cell-intrinsic differences between stem cells from
different regions of the peripheral nervous system regulate the
generation of neural diversity. Neuron. 35:643–656. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24−/low/CD44+ breast
cancer-initiating cells to radiation. J Natl Cancer Inst.
98:1777–1785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chiou SH, Kao CL, Chen YW, Chien CS, Hung
SC, Lo JF, Chen YJ, Ku HH, Hsu MT and Wong TT: Identification of
CD133-positive radioresistant cells in atypical teratoid/rhabdoid
tumor. PLoS One. 3:e20902008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ogawa K, Yoshioka Y, Isohashi F, Seo Y,
Yoshida K and Yamazaki H: Radiotherapy targeting cancer stem cells:
Current views and future perspectives. Anticancer Res. 33:747–754.
2013.PubMed/NCBI
|
|
40
|
Wang J, Wakeman TP, Lathia JD, Hjelmeland
AB, Wang XF, White RR, Rich JN and Sullenger BA: Notch promotes
radioresistance of glioma stem cells. Stem Cells. 28:17–28.
2010.
|
|
41
|
Chen YC, Hsu HS, Chen YW, Tsai TH, How CK,
Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ieta K, Tanaka F, Haraguchi N, Kita Y,
Sakashita H, Mimori K, Matsumoto T, Inoue H, Kuwano H and Mori M:
Biological and genetic characteristics of tumor-initiating cells in
colon cancer. Ann Surg Oncol. 15:638–648. 2008. View Article : Google Scholar
|
|
43
|
Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y,
Zhang J, Yuan J, Wang M, Chen D, Sun Y, et al: ATM-mediated
stabilization of ZEB1 promotes DNA damage response and
radioresistance through CHK1. Nat Cell Biol. 16:864–875. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Suvà ML, Rheinbay E, Gillespie SM, Patel
AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, et
al: Reconstructing and reprogramming the tumor-propagating
potential of glioblastoma stem-like cells. Cell. 157:580–594. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Seguin L, Kato S, Franovic A, Camargo MF,
Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, et
al: An integrin β3-KRAS-RalB complex drives tumour
stemness and resistance to EGFR inhibition. Nat Cell Biol.
16:457–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar
|
|
47
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ, et al: A microRNA polycistron as a potential human
oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cui FB, Liu Q, Li RT, Shen J, Wu PY, Yu
LX, Hu WJ, Wu FL, Jiang CP, Yue GF, et al: Enhancement of
radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli
PEG-Pep-PCL nanoparticles in gastric cancer cells. Int J Nanomed.
13:2345–2358. 2014.
|
|
51
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yao HP, Zhou YQ, Zhang R and Wang MH:
MSP-RON signalling in cancer: Pathogenesis and therapeutic
potential. Nat Rev Cancer. 13:466–481. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Blazek ER, Foutch JL and Maki G: Daoy
medulloblastoma cells that express CD133 are radioresistant
relative to CD133− cells, and the CD133+
sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys.
67:1–5. 2007. View Article : Google Scholar
|
|
54
|
Kim HM, Haraguchi N, Ishii H, Ohkuma M,
Okano M, Mimori K, Eguchi H, Yamamoto H, Nagano H, Sekimoto M, et
al: Increased CD13 expression reduces reactive oxygen species,
promoting survival of liver cancer stem cells via an
epithelial-mesenchymal transition-like phenomenon. Ann Surg Oncol.
19(Suppl 3): S539–S548. 2012. View Article : Google Scholar
|
|
55
|
Kim JJ and Tannock IF: Repopulation of
cancer cells during therapy: An important cause of treatment
failure. Nat Rev Cancer. 5:516–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Grün R, Friedrich T, Elsässer T, Krämer M,
Zink K, Karger CP, Durante M, Engenhart-Cabillic R and Scholz M:
Impact of enhancements in the local effect model (LEM) on the
predicted RBE-weighted target dose distribution in carbon ion
therapy. Phys Med Biol. 57:7261–7274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Durante M and Loeffler JS: Charged
particles in radiation oncology. Nat Rev Clin Oncol. 7:37–43. 2010.
View Article : Google Scholar
|
|
58
|
Jingu K, Tsujii H, Mizoe JE, Hasegawa A,
Bessho H, Takagi R, Morikawa T, Tonogi M, Tsuji H, Kamada T, et al
Organizing Committee for the Working group for head-and-neck
Cancer: Carbon ion radiation therapy improves the prognosis of
unresectable adult bone and soft-tissue sarcoma of the head and
neck. Int J Radiat Oncol Biol Phys. 82:2125–2131. 2012. View Article : Google Scholar
|
|
59
|
Ishikawa H, Tsuji H, Kamada T, Akakura K,
Suzuki H, Shimazaki J and Tsujii H; Working Group for Genitourinary
Tumors: Carbon-ion radiation therapy for prostate cancer. Int J
Urol. 19:296–305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kato S, Ohno T, Tsujii H, Nakano T, Mizoe
JE, Kamada T, Miyamoto T, Tsuji H, Kato H, Yamada S, et al Working
group of the Gynecological Tumor: Dose escalation study of carbon
ion radiotherapy for locally advanced carcinoma of the uterine
cervix. Int J Radiat Oncol Biol Phys. 65:388–397. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kato H, Tsujii H, Miyamoto T, Mizoe JE,
Kamada T, Tsuji H, Yamada S, Kandatsu S, Yoshikawa K, Obata T, et
al Liver Cancer Working Group: Results of the first prospective
study of carbon ion radiotherapy for hepatocellular carcinoma with
liver cirrhosis. Int J Radiat Oncol Biol Phys. 59:1468–1476. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Miyamoto T, Baba M, Sugane T, Nakajima M,
Yashiro T, Kagei K, Hirasawa N, Sugawara T, Yamamoto N, Koto M, et
al Working group for Lung Cancer: Carbon ion radiotherapy for stage
I non-small cell lung cancer using a regimen of four fractions
during 1 week. J Thorac Oncol. 2:916–926. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Mizoe JE, Hasegawa A, Jingu K, Takagi R,
Bessyo H, Morikawa T, Tonoki M, Tsuji H, Kamada T, Tsujii H, et al
Organizing Committee for the Working Group for Head Neck Cancer:
Results of carbon ion radiotherapy for head and neck cancer.
Radiother Oncol. 103:32–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Nakano T, Suzuki Y, Ohno T, Kato S, Suzuki
M, Morita S, Sato S, Oka K and Tsujii H: Carbon beam therapy
overcomes the radiation resistance of uterine cervical cancer
originating from hypoxia. Clin Cancer Res. 12:2185–2190. 2006.
View Article : Google Scholar : PubMed/NCBI
|
